Status:
COMPLETED
Effects of Exenatide on Motor Function and the Brain
Lead Sponsor:
University of Florida
Collaborating Sponsors:
National Institute of Neurological Disorders and Stroke (NINDS)
Conditions:
Parkinson's Disease
Eligibility:
All Genders
40-77 years
Phase:
PHASE1
Brief Summary
The purpose of this research study is to investigate how the brain and motor behavior changes Parkinson's Disease (PD) over time in response to Exenatide. In previous clinical trials, PD patients have...
Detailed Description
Participants will receive baseline testing to confirm a diagnosis of Parkinson's Disease and to determine eligibility in the research study. All of the participants in this study will receive the stud...
Eligibility Criteria
Inclusion
- patients clinically diagnosed with Parkinson's disease (PD) through use of the UK PD brain bank diagnostic criteria
- early stage PD patients within 5 years of diagnosis who have never taken Exenatide for any reason
- PD patients with a Hoehn and Yahr stage less than or equal to 2 when on medication
- patients able and willing to sign informed consent.
Exclusion
- individuals who have any type of implanted electrical device (such as a cardiac pacemaker or a neurostimulator)
- individuals with a certain type of metallic clip in the body (i.e., an aneurysm clip in the brain)
- claustrophobia
- women who are or might be pregnant and nursing mothers. Pregnancy tests will be carried out for each female subject prior to the MRI scan.
- psychiatric disorders or dementia
- other neurologic and orthopedic problems that impair hand movements and walking
- individuals actively participating in another trial of a device, drug or surgical treatment for Parkinson's disease
- individuals who have a history metalworking involving cutting processes such as grinding, filing, shaving, and threading, will need radiological clearance to participate in this study. Specifically, individuals who report a history of metalworking will be referred to Radiology at Shands University of Florida(UF) for an orbitofrontal x-ray.
- individuals who have sustained an eye injury involving metal will also be referred to Radiology at Shands UF for an orbitofrontal x-ray.
- prior stroke or brain tumor
- cognitive impairment as assessed by a Montreal Cognitive Assessment score \< 23
- individuals unwilling to comply with the study procedures
- history of gallstones, digestion problems (such as gastroparesis), severe gastrointestinal disease, history of pancreatitis, a thyroid tumor or cancer, pancreas tumor, or kidney problems
- severely impaired renal function with creatinine clearance less than 30 ml/min
- hyperlipidemia defined as more than two times the upper limit of normal
- body mass index less than 18.5
- previous exposure to Exenatide
- diabetes
Key Trial Info
Start Date :
June 5 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 25 2021
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT03456687
Start Date
June 5 2018
End Date
August 25 2021
Last Update
September 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laboratory for Rehabilitation Neuroscience
Gainesville, Florida, United States, 32611